Biomedical Engineering Reference
In-Depth Information
209. Allen, T. M.; Mumbengegwi, D. R.; Charrois, G. J. Anti-CD19-targeted Liposomal Doxorubi-
cin Improves the Therapeutic Efficacy in Murine B-Cell Lymphoma and Ameliorates the Tox-
icity of Liposomes with Varying Drug Release Rates.
Clin. Cancer. Res.
2005,
11,
3567-3573.
210. Barreiro, A.; Rurali, R.; Harnandez, E. R.; Moser, J.; Pichler, T. F. L., et al. Subnanometer
Motion of Cargos Driven by Thermal Gradients along Carbon Nanotubes.
Science
2008,
320,
775-778.
211. Brigger, I.; Dubernet, C.; Couvreur, P. Nanoparticles in Cancer Therapy and Diagnosis.
Adv.
Drug Del. Rev.
2002,
54,
631-651.
212. Chauhan, A.; Sridevi, S.; Chalasani, K.; Jain, A.; Jain, S.; Jain, N.; Diwan, P. Dendrimer-
Mediated Transdermal Delivery: Enhanced Bioavailability of Indomethacin.
J. Contr. Release
2003,
90,
335.
213. Couvreur, P.; Barratt, G.; Fattal, E.; Legrand, P.; Vauthier, C. Nanocapsule Technology: A
Review.
Crit. Rev. Ther. Drug Carrier Syst.
2002,
19,
99134.
214. Dang, J. M.; Leong, K. W. Natural Polymers for Gene Delivery and Tissue Engineering.
Adv.
Drug. Deliv. Rev.
2006,
58,
487-499.
215. Fetterly, G. J.; Straubinger, R. M. Pharmacokinetics of Paclitaxel-Containing Liposomes in
Rats.
AAPS PharmSci.
2003,
5,
1-11.
216. Govender, T.; Riley, T.; Ehtezazi, T.; Garnett, M. C.; Stolnik, S.; Illum, L.; Davis, S. S. Defin-
ing the Drug Incorporation Properties of PLA-PEG Nanoparticles.
Int. J. Pharm.
2000,
199,
95-110.
217. Govender, T.; Stolnik, S.; Garnett, M. C.; Illum, L.; Davis, S. S. PLGA Nanoparticles Prepared
by Nanoprecipitation: Drug Loading and Release Studies of a Water Soluble Drug.
J. Contr.
Release
1999,
57,
171-185.
218. Kroll, R. A.; Pagel, M. A.; Muldoon, L. L.; Roman-Goldstein, S.; Fiamengo, S. A.; Neuwelt,
E. A. Improving Drug Delivery to Intracerebral Tumor and Surrounding Brain in a Rodent
Model: A Comparison of Osmotic Versus Bradykinin Modification of the Blood-Brain and/or
Blood-Tumor Barriers.
Neurosurgery
1998,
43,
879-886.
219. Labhasetwar, V. Nanotechnology for Drug and Gene Therapy: The Importance of Understand-
ing Molecular Mechanisms of Delivery.
Curr. Opin. Biotechnol.
2005,
16,
674-680.
220. Lamprecht, A.; Ubrich, N.; Yamamoto, H.; Schäfer, U.; Takeuchi, H.; Maincent, P.;
Kawashima, Y.; Lehr, C. M. Biodegradable Nanoparticles for Targeted Drug Delivery in Treat-
ment of Inflammatory Bowel Disease.
J. Pharmacol. Exp. Ther.
2001,
299,
775-781.
221. Medina, O. P.; Pillarsettya, N.; Glekasa, A.; Punzalan, B.; Longo, V.; Gonen, M.; Zanzonico, P.;
Smith-Jones, P.; Larson, S. M. Optimizing Tumor Targeting of the Lipophilic EGFR-Binding
Radiotracer SKI 243 using a Liposomal Nanoparticle Delivery System.
J Contr. Release
2011,
149,
292-298.
222. Moghimi, S. M.; Hunter, A. C.; Murray, J. C. Long-Circulating and Target-Specific Nanopar-
ticles: Theory to Practice.
Pharmacol. Rev.
2003,
53,
283-318.
223. Panyam, J.; Labhasetwar, V. Biodegradable Nanoparticles for Drug and Gene Delivery to
Cells and Tissue.
Adv. Drug. Deliv. Rev.
2003,
12,
329-347.
224. Sapra, P.; Allen, T. M. Ligand-Targeted Liposomal Anticancer Drugs.
Prog. Lipid. Res.
2003,
42,
439-462.
225. Kateb, B.; Chiu, K.; Black, K.; Yamamoto, V.; Khalsa, B.; Ljubimova, J.; Ding, H.; Patil, R.;
Portilla-Arias, J.; Modo, M.; Moore, D.; Farahani, K.; Okun, M.; Prakash, N.; Neman, J.;
Ahdoot, D.; Grundfest, W.; Nikzad, S.; Heiss, J. Nanoplatforms for Constructing New
Approaches to Cancer Treatment, Imaging, and Drug Delivery: What should be the Policy?.
NeuroImage
2011,
54,
S106-S124.
